E. Graff
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
- Surgery 13
- Lipoproteins and Cardiovascular Health 5
- Co-authors
- Uri Goldbourt (8 shared papers)Yaffa Vered (14 shared papers)Henrietta Reicher-Reiss (10 shared papers)D. Brunner (13 shared papers)Michal Benderly (8 shared papers)Solomon Behar (5 shared papers)David Tanné (3 shared papers)J. M. Rabey (10 shared papers)
In The Last Decade
E. Graff
67 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 111
- Endocrinology, Diabetes and Metabolism 306
- Nephrology 120
- Behavioral Neuroscience 56
- Biological Psychiatry 37
- Psychiatry and Mental health 169
Countries citing papers authored by E. Graff
This map shows the geographic impact of E. Graff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Graff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Graff more than expected).
Fields of papers citing papers by E. Graff
This network shows the impact of papers produced by E. Graff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Graff. The network helps show where E. Graff may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Graff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 131 | |
| 2 | 1999 | 123 | |
| 3 | 2001 | 120 | |
| 4 | 1996 | 104 | |
| 5 | Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. | 1998 | 82 |
| 6 | 1992 | 77 | |
| 7 | The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. | 1996 | 72 |
| 8 | 1999 | 58 | |
| 9 | 1992 | 53 | |
| 10 | 1995 | 49 | |
| 11 | 1998 | 46 | |
| 12 | 1992 | 40 | |
| 13 | 2001 | 39 | |
| 14 | 1987 | 36 | |
| 15 | 1997 | 35 | |
| 16 | 1989 | 35 | |
| 17 | Broad bean (Vicia faba) consumption and Parkinson's disease. | 1993 | 34 |
| 18 | 1997 | 32 | |
| 19 | 1995 | 31 | |
| 20 | 1986 | 30 |
About E. Graff
E. Graff is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Psychiatry and Mental health, Pulmonary and Respiratory Medicine and Genetics, having authored 68 papers that have together received 1.8k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Bipolar Disorder and Treatment (7 papers), Parkinson's Disease Mechanisms and Treatments (6 papers), Blood properties and coagulation (5 papers), Lipoproteins and Cardiovascular Health (5 papers), Epilepsy research and treatment (3 papers), Schizophrenia research and treatment (3 papers) and Genetic Associations and Epidemiology (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (306 citations), Nephrology (120 citations), Behavioral Neuroscience (56 citations), Biological Psychiatry (37 citations) and Psychiatry and Mental health (169 citations). E. Graff has collaborated with scholars based in Israel and Germany. Frequent co-authors include Uri Goldbourt, Yaffa Vered, Henrietta Reicher-Reiss, D. Brunner, Michal Benderly, Solomon Behar, David Tanné, J. M. Rabey, Michal Yaron and Nira Koren‐Morag. Their work appears in journals such as Biological Psychiatry, Clinical Neuropharmacology, Atherosclerosis, Circulation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.